Tenapanor May Improve Uncontrolled Hyperphosphatemia
By blocking paracellular phosphate transport, tenapanor added to phosphate binders may improve the hyperphosphatemia management in patients on maintenance dialysis, a study found.
By blocking paracellular phosphate transport, tenapanor added to phosphate binders may improve the hyperphosphatemia management in patients on maintenance dialysis, a study found.
In a study, use of “high” dialysate calcium of 3.5 mEq/L in new hemodialysis patients was associated with poor outcomes.
People with breathing and heart problems, children, and the elderly may be particularly sensitive to fine particulate matter in the air.
The proportion of hemodialysis patients with congestive heart failure was 21% for those living below 1000 feet vs 19% and 13% for those living at 1000 to 4000 feet and above 4000 feet, respectively, a study found.
In the hemodialysis population, women have a 48% decreased risk of death compared with men in adjusted analyses, a study found.
Patients with low BMI had higher mortality risk even at higher spKt/V compared with patients with normal BMI and target range spKt/V of 1.2 to less than 1.4.
In a study of new dialysis patients, low proteinuria was associated with nearly triple the risk for early mortality compared with relatively normal proteinuria.